Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Insecticide danger to bees addressed
European report looks at chemical risk

A report by the European Food Safety Authority (EFSA) has deemed the world's most widely-used insecticide an unacceptable danger to bees.

The report was demanded by the European commission in April, following two major studies earlier in the spring that found a link between the use of neonicotinoids and the UK's decline in bees. Further studies have been produced since.

Bees and other pollinators are critical to one-third of all food, therefore, the report examined the risk posed by the chemicals, including the widely-used insecticide, imidacloprid.

Working together with experts from across Europe, EFSA's report concluded that the use of imidacloprid would only be considered acceptable on crops that honeybees are not attracted to.

EFSA added that it found a widespread lack of information in many areas, earlier stating that current "simplistic" regulations contained "major weaknesses".

Andrew Pendleton, of Friends of the Earth, said: "This is a major turning point in the battle to save our bees. EFSA have sounded the death knell for one of the chemicals most frequently linked to bee decline and cast serious doubt over the safety of the whole neonicotinoid family."

However, a spokesperson for the company that produces imidaclopid, said: "The company is ready to work with the European commission and member states to address the perceived data gaps.

"We believe it is very important that any political decision relating to registrations of neonicotinoid-containing products should be based on clear, scientific evidence of adverse effects."

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.